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Selection of reference genes is 
critical for miRNA expression 
analysis in human cardiac tissue. A 
focus on atrial fibrillation
Michela Masè1, Margherita Grasso2, Laura Avogaro1,2, Elvira D’Amato1, 
Francesco Tessarolo3,4, Angelo Graffigna5, Michela Alessandra Denti2,* & Flavia Ravelli1,*
MicroRNAs (miRNAs) are emerging as key regulators of complex biological processes in several 
cardiovascular diseases, including atrial fibrillation (AF). Reverse transcription-quantitative polymerase 
chain reaction is a powerful technique to quantitatively assess miRNA expression profile, but reliable 
results depend on proper data normalization by suitable reference genes. Despite the increasing 
number of studies assessing miRNAs in cardiac disease, no consensus on the best reference genes has 
been reached. This work aims to assess reference genes stability in human cardiac tissue with a focus on 
AF investigation. We evaluated the stability of five reference genes (U6, SNORD48, SNORD44, miR-16, 
and 5S) in atrial tissue samples from eighteen cardiac-surgery patients in sinus rhythm and AF. Stability 
was quantified by combining BestKeeper, delta-Cq, GeNorm, and NormFinder statistical tools. All 
methods assessed SNORD48 as the best and U6 as the worst reference gene. Applications of different 
normalization strategies significantly impacted miRNA expression profiles in the study population. 
Our results point out the necessity of a consensus on data normalization in AF studies to avoid the 
emergence of divergent biological conclusions.
MicroRNAs (miRNAs) are small (approximately 22 base pairs), single stranded, non-coding RNA molecules that 
finely regulate gene expression at the post-transcriptional level. miRNAs are involved in a variety of physiolog-
ical and pathophysiological processes, which range from cell development and differentiation to apoptosis and 
oncogenesis1. Compelling evidence supports the role of miRNAs in normal cardiac development and in cardiac 
disease. Distinctive miRNAs signatures have been associated with heart failure, cardiac hypertrophy, and myo-
cardial infarction2–4. More recently attention has been posed on the role of miRNAs as molecular determinants 
of atrial fibrillation (AF). AF is the most common sustained cardiac arrhythmia in the clinical practice, with 33.5 
millions of people affected in 2010 and about 5 millions of new cases each year5. AF is associated with pronounced 
cardiovascular morbidity and mortality, mostly due to an increased risk of stroke. AF is a multi-factorial disease, 
supported by altered electrophysiological and structural factors6. A growing body of works suggests miRNAs to 
act as potential mediators in the electrophysiological and structural remodeling of the atria maintaining AF7–9.
The regulatory function of miRNAs in cardiac disease and AF supports their utilization as prognostic and 
predictive biomarkers as well as therapeutic targets. This requires, however, a reliable and quantitative assessment 
of miRNA expression. Although different methodologies can be applied to evaluate miRNA expression, reverse 
transcription-quantitative polymerase chain reaction (RT-qPCR) remains the gold-standard for a specific detec-
tion of selected sets of miRNAs10,11. Normalization of expression levels is a crucial step to ensure accurate and 
suitable quantification of PCR data12–14. Normalization is aimed to differentiate true biological variations, explain-
ing the investigated phenotype, from non-specific experimentally-induced alterations. Indeed factors, such as 
sample collection and preservation, amount of raw material, enzyme efficiency, RNA integrity, can artefactually 
alter expression levels. To date normalization by one or a set of internal reference genes is generally accepted to 
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normalize miRNA expression12. Ideal reference genes should show no (or minimal) expression variation in the 
tissue or cells under investigation, or in response to experimental treatment/disease condition. Since no normali-
zation standard has been proven to be ideal yet, it is essential to verify the expression stability of putative normal-
izers in each experimental setup, and in relation to the specific tissue, species, and disease under investigation. 
Despite the growing number of studies investigating miRNA expression in human AF7–9, at present no consensus 
exists on the reference genes for human atrial tissue samples. This may limit study comparison and, most impor-
tantly, lead to ambiguous data interpretation and misleading biological conclusions.
This study aimed to quantitatively assess the performance of five reference genes of different RNA classes 
(5S ribosomal RNA (rRNA), hsa-miR-16-5p, U6 small nuclear RNA (snRNA), SNORD44 and SNORD48 small 
nucleolar RNAs (snoRNAs)), previously adopted for miRNA normalization in the cardiac tissue (Table 1). The 
stability of reference genes was assessed on human atrial tissue samples from cardiac surgery patients in normal 
sinus rhythm (SR) and AF. Indeed cardiac surgery constitutes the most common experimental set-up for the 
study of miRNA regulation in human AF. Performance was quantified by combining multiple gold-standard 
statistical tools (BestKeeper15, GeNorm16, NormFinder17 and the comparative delta-Cq method18), which assess 
different aspects involved in the concept of gene “stability”13. Finally, the impact of adopting different normaliza-
tion strategies was demonstrated in the exemplifying case of the quantification of miR-499a-5p expression in the 
study population.
Results
RNA quantity and integrity. Quantity and integrity data of the total RNA among atrial tissue samples are 
reported in Supplementary Table S1. The extracted amount of total RNA varied among samples with a median 
concentration of 117.3 ng/μl (interquartile range (IQR): 91.4–246.2 ng/μl). Integrity was adequate for the analysis 
in all the samples, with a median value of 7.85 (IQR: 7.0–8.2).
Reference gene stability. Best Keeper. The distributions of the qPCR quantification cycle (Cq) values of 
the five reference genes over the whole sample set are shown in Fig. 1, while the descriptive statistics given by 
BestKeeper are reported in Table 2. Reference genes showed different expression values and variability levels. 5S 
showed the largest expression (mean Cq = 18.97), while SNORD44 was the least expressed (mean Cq = 26.77). In 
terms of variability, miR-16 and SNORD48 displayed the lowest standard deviation (SD) values of 0.70 and 0.72, 
respectively. Conversely, 5S and U6 showed variability levels beyond the limit of acceptance for reliable normal-
izers (>1). Correlation analysis was performed between each pair of reference genes and between each reference 
gene and the BestKeeper Index (BKI). In particular, BKI (5) was calculated including all reference genes, while 
BKI (3) was obtained excluding the two genes with unacceptable variability (U6 and 5S). The analysis, shown 
in Table 2 and in Supplementary Table S2, pointed out the existence of significant correlations for SNORD48, 
SNORD44 and 5S when compared to one another, and for U6 when compared to 5S, while miR-16 did not 
Reference Gene/Alias
HUGO gene 
abbreviation RNA class
Chromosome 
Location NCBI reference References
5S; r5S RN5S1@ Ribosomal RNA (rRNA) 1q42.11-q42.13 V00589.1 Zhang Y et al.
41
hsa-miR-16-5p; miR-16 MIR16-1 microRNA (miRNA) 13q14.2 LM378756.1 Nishi H et al.29 Roy S et al.42
SNORD44 U44 RNU44 SNORD44 Small nucleolar RNA (snoRNA) 1q25.1 NR_002750.2 Ferreira LR et al.
43
SNORD48; U48; RNU48 SNORD48 Small nucleolar RNA (snoRNA) 6p21.33 NR_002745 Sauer E et al.
19
U6; RNU6
Not available 
from the 
provider
Small nuclear RNA 
(snRNA)
Not available 
from the provider
Not available 
from the 
provider
Satoh M et al.44 Cooley N et al.28 
Adam O et al.45 Villar AV et al.46 
García R et al.47 Song CL et al.48  
Liu H et al.32 Dong S et al.49
Table 1.  Specifications of the five reference genes under evaluation.
Figure 1. qPCR quantification cycle (Cq) values of the five reference genes in the atrial tissue sample 
dataset. For each distribution values are given as median (solid line), interquartile range (IQR, box), lower and 
superior adjacent values at 1.5 × IQR (whiskers), and outliers (black plus sign markers).
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correlate with any other reference gene. Consistently, all reference genes but miR-16 correlated with BKI (5). 
When compared with BKI (3), SNORD48 and SNORD44 showed the highest correlations (r > 0.8 and p < 0.001), 
while miR-16 displayed a lower, non significant correlation value (r = 0.45, p = 0.06). Considering both variability 
and correlation information, SNORD48 showed the best performance, combining a low SD value with high cor-
relation values.
GeNorm. The analysis of gene stability performed by GeNorm is reported in Fig. 2a. The procedure of step-wise 
exclusion of the candidate genes indicated U6 as the worst reference gene (M-value = 1.67), and identified 
SNORD48 and SNORD44 as the most stable pair of genes (M-value = 0.64). Pairwise variation analysis showed 
no combination of N > 2 candidate genes leading to a decrease in variation <0.15. The GeNorm manual suggests 
the use of minimum the three most stable reference genes in such situations.
Comparative delta-Cq method. Similarly to GeNorm, the comparative delta-Cq method (Fig. 2b) indicated U6 
and miR-16 as the least stable genes, since they displayed the highest average SD of Cq differences for pairwise 
comparisons (2.00 and 1.88, respectively). The most stable genes were SNORD48 and SNORD44 with average SD 
of 1.37 and 1.45, respectively.
NormFinder. The stability analysis performed by NormFinder is displayed in Fig. 2c in terms of stability index ρ 
(upper panel) and inter-group (box) and intra-group (whiskers) variations (lower panel). The worst overall per-
formance was shown by U6 (ρ = 0.54), which displayed large values of both inter-group (−0.37) and intra-group 
variability (1.12). Overall performance was low also for 5S and miR-16 (ρ = 0.42 and 0.46), mainly due to high 
intra-group variability values (0.67 and 1.36). Best overall performance was observed for SNORD48 (ρ = 0.34), 
which displayed intermediate inter-group variation (0.25) and the smallest intra-group variability (0.06).
The average stability index ρA, calculated for each pair of reference genes, showed that stability could be 
improved by using combination of reference genes with intergroup variability of opposite sign. In particular, 
combination of either of SNORD48 and SNORD44 with U6 led to an average stability index of ρA = 0.27, while 
combination with 5S led to a stability index of ρA = 0.29.
The comprehensive ranking of gene stability obtained by combining the four analyses (Fig. 3 and Table 3) 
assessed SNORD48 as the most stable gene (best performance according to all analyses), followed by SNORD44, 
5S, and miR-16. U6 was the least stable gene, displaying the worst performance according to all analyses.
Impact of normalization strategy on miR-499a-5p profiling. The effects of normalization strategy on 
target miRNA profiles were evaluated in the exemplifying case of miR-499a-5p. The expression levels in AF versus 
SR groups were computed using either the best (SNORD48) and worst (U6) normalizer. Results in Fig. 4 show 
that miR-499a-5p expression levels in the two groups were strongly affected by the normalization process. When 
normalizing to SNORD48, a significant (p < 0.05) overexpression of miR-499a-5p was observed in the AF versus 
SR group (left panel). Conversely, normalization by U6 led to an increased variability of expression and the loss of 
any subgroup expression difference (right panel).
Discussion
This study assessed for the first time the stability properties of putative normalizers for miRNA expression 
profiling in human atrial tissue, with focus on the study of AF. By a multi-technique quantitative approach we 
demonstrated the poor performance of widely-used normalizers, such as U6, in this specific experimental con-
text, and suggested a potential suitable alternative in the small nucleolar RNA SNORD48. The application of 
different normalization strategies in the exemplary case of miR-499a-5p assessment pointed out the criticality of 
the choice of reference genes to obtain reliable information on miRNA deregulation in AF.
The advent of RT- qPCR and qPCR has opened the possibility of a quantitative assessment of miRNA expres-
sion profiles. The higher sensitivity of the technique has fixed higher standard for reference gene variability, which 
Reference Genes U6 miR-16 5S SNORD48 SNORD44 BKI (N = 5) BKI (N = 3)
n. samples 18 18 18 18 18 18 18
geo Mean [Cq] 25.72 23.30 18.88 25.29 26.73 23.81 25.07
ar Mean [Cq] 25.79 23.32 18.97 25.30 26.77 23.83 25.08
Min [Cq] 22.49 20.75 15.17 23.88 24.34 21.82 23.86
Max [Cq] 28.46 24.91 21.49 26.78 28.90 25.22 26.78
SD [ ± Cq] 1.62 0.70 1.28 0.72 1.06 0.72 0.61
CV [% Cq] 6.29 3.01 6.76 2.84 3.97 3.02 2.44
r with BKI (N = 5) (p-value) 0.69 (<0.002) 0.08 (0.77) 0.92 (<0.001) 0.69 (<0.002) 0.76 (<0.001) — —
r with BKI (N = 3) (p-value) NA 0.45 (0.06) NA 0.85 (<0.001) 0.86 (<0.001) — —
Table 2. BestKeeper descriptive statistics and correlation analysis of the five reference genes. 
Ar = arithmetic; BKI = BestKeeper Index, calculated over all reference genes (N = 5) or excluding the two 
genes with the highest variability (N = 3); Cq = qPCR quantification cycle; CV = coefficient of variation; 
geo = geometric; Min = minimal value; Max = maximal value; r = Pearson’s linear correlation coefficient; 
SD = standard deviation.
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should have prompted a re-evaluation of previously used normalization strategies. A large number of studies have 
been carried out concerning the validation of reference genes in different tissue and cell types19–24. Nonetheless, 
studies on the best normalization strategy in cardiac tissue remain sparse25–27, and, to the best of our knowledge, 
no previous study has been performed to identify appropriate reference genes in the human atrial tissue for the 
study of AF. The lack of a general consensus on the best normalization strategy in this context has significant 
impact, considering the large increase in the number of studies analyzing the relationship between miRNA and 
AF in the last five years7–9. A variety of normalization strategies has been applied in different studies, which 
however were not validated in the specific experimental context of application28,29. The absence of a common 
normalization approach and the use of unvalidated reference genes may not only hinder the comparison of results 
in different studies, but also call into question the reliability and biological meaning of these results.
Figure 2. Evaluation of gene expression stability in the atrial tissue sample dataset calculated by: GeNorm (a), 
comparative delta-Cq method (b), and NormFinder (c). (a) Step-wise exclusion of the least stable reference 
genes, based on M-stability index. (b) Average variability (SD) of the Cq differences (ΔCq) calculated for each 
reference gene versus the remaining genes. (c) In the upper panel, overall stability index (ρ) of each candidate 
gene and, in the lower panel, corresponding intergroup (box) and intra-group (whiskers) variability. Note that 
genes are ranked right to left from the most to the least stable in panel a, and left to right in panels (b and c). See 
text for details.
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The present study addressed the issue of miRNA normalization in the atrial tissue of SR and AF patients by 
an empirical and quantitative approach. We evaluated the performance of a set of five reference genes of differ-
ent RNA classes (small nuclear/nucleolar RNAs, ribosomal RNA and miRNA), which have been widely used in 
different contexts, including AF. Since we focused on miRNA normalization, messenger RNA (mRNA) reference 
genes, such as GAPDH, were excluded from our set of reference genes. Indeed, being much bigger in size than 
miRNAs, mRNAs might differ from miRNAs in terms of stability, efficiency of extraction, reverse transcription 
and PCR amplification. The quantitative evaluation of reference genes was based on the combination of four com-
plementary statistical approaches, which are currently considered the gold standard for the selection of appro-
priate reference genes for normalization in gene expression experiments involving qPCR13. The multi-technique 
evaluation of reference genes allowed us to take into account different aspects related to the concept of gene 
stability, such as overall variability, similarity and correlation of expression patterns, inter/intra-group variability. 
Figure 3. Overall ranking of the five reference genes. The overall positioning is calculated as the geometric 
mean of the rankings obtained by BestKeeper, GeNorm, comparative delta-Cq, and NormFinder statistical tools. 
Genes are ordered left to right from the most to the least stable. SNORD48 displayed the best overall ranking.
Rank Gene
Overall 
Ranking
BestKeeper GeNorm Delta Ct NormFinder 
 SD(Cq) r, BKI (N = 3) M value SD(ΔCq) ρ value
1 SNORD48 1 0.72 0.85 0.64 1.37 0.34
2 SNORD44 1.9 1.06 0.86 0.64 1.45 0.39
3 5S 3.2 1.28 NA 1.18 1.66 0.42
4 miR-16 3.4 0.70 0.45 1.45 1.88 0.46
5 U6 5 1.62 NA 1.67 2.00 0.54
Table 3.  Overall stability of candidate reference genes according to the four evaluation algorithms. Genes 
are ordered according to the comprehensive ranking given by the geometric mean of the rankings obtained 
by the four analyses. BKI = BestKeeper Index, calculated excluding the two genes with the highest variability 
(N = 3); Cq = qPCR quantification cycle; SD(ΔCq) = average standard deviation of Cq differences; NA = not 
assigned; r = Pearson’s linear correlation coefficient; SD = standard deviation.
Figure 4. Effects of normalization strategy on miRNA expression profile. Normalized expressions of  
miR-499a-5p in sinus rhythm (SR, green box) versus atrial fibrillation (AF, red box) patients, calculated using 
the best (SNORD48, left) and the worst (U6, right) reference gene. For each distribution values are given as 
median (solid line), interquartile range (IQR, box), lower and superior adjacent values at 1.5 × IQR (whiskers), 
and outliers (black plus sign markers). nu, normalized units. *p < 0.05.
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Previous studies showed that statistical approaches, based on different definitions of stability, may sometimes lead 
to different ranking of reference genes30. Thus an overall evaluation of the performance by combined measures 
is desirable31. On the other hand, the fact that in our analysis four independent algorithms agreed in ranking the 
most and least stable reference genes adds a level of consistency to the obtained results.
The multi-technique approach provided the following ranking of the candidate reference genes, from the 
most to the least stable: SNORD48, SNORD44, 5S, miR-16, U6. Small nuclear/nucleolar RNAs, such as U6, 
SNORD44 and SNORD48, have been commonly used for miRNA normalization, thanks to their RNA stabil-
ity and abundant expression. Nonetheless, in contrast with its frequent use as normalizer in different contexts, 
including the study of AF28,32, our validation methods consistently ranked U6 as the worst reference gene of the 
set. Indeed it displayed the highest variability across the entire population compared to the other transcripts, the 
highest M-value and intergroup variability, suggesting its unsuitability as reference gene in human AF. Instability 
of U6 has been previously reported in samples from hepatic and liver tissues20, renal cell carcinomas23, endo-
metrial22 and prostate24 cancer tissues. In addition, a disease-specific dysregulation of U6 has been suggested 
by Benz et al.33. They observed a high variability of U6 expression in the serum of healthy volunteers, intensive 
care unit and liver fibrosis patients, and a significant correlation of U6 with established inflammation markers33. 
Since an inflammation state may be linked to cardiac valve disease leading to cardiac surgery34, U6 deregulation 
with inflammation might partially explain the bad performance of the reference gene in atrial samples from a 
cardiac-surgery setting. In contrast with these negative results, U6 was assessed among the most stable control 
genes in the rat heart26. Differences in stability may be related to differences in species and experimental setting 
and/or to pathology-specific effects. This points out the inappropriateness of simply transposing reference genes 
from study to study and the necessity of an empirical case-by-case validation.
Differently from U6, the two nucleolar RNAs, SNORD44 and SNORD48, displayed the best performance 
of all candidate genes, ranking second and first, respectively. In particular, SNORD48 showed expression levels 
higher than SNORD44, low overall variability of expression and intra-group variation, and high correlation and 
similarity of expression with the other reference genes. These features resulted in the best scores according to all 
algorithms. Consistently with our results, SNORD48, SNORD75 and SNORD44 were scored among the most sta-
bly and equivalently expressed reference genes in tissue samples of endometroid endometrial carcinoma patients 
and normal samples, displaying better performance than miR-16 and U622. In addition, SNORD48 resulted the 
most stably expressed reference gene in a large set of forensically relevant organ tissues19, as well as in renal cell 
carcinoma23.
Our study revealed intermediate performance of the ribosomal RNA 5S and of miR-16. Consistently with its 
structural role in the large ribosomal subunit, 5S displayed the highest expression levels of all candidate genes. 
Expression levels significantly larger than target RNAs may raise concerns on the use of 5S as a normalizer, since 
it may be complex to quantify the ribosomal RNA and a rare target in the same RNA dilution. In addition we 
observed a large variability in the overall expression of 5S, which may further reduce its performance as normal-
izer. Conversely, the use of miRNAs, such as miR-16, as reference genes in miRNA normalization may be sup-
ported, since being of the same RNA class, they should have similar efficiency in extraction, reverse transcription 
and PCR amplification. In our analysis miR-16 presented low overall variability and inter-group variability, but 
its overall performance was degraded by a high intra-group variation and expression patterns dissimilar from 
the other reference genes. The low correlation and dissimilarity in expression may be partially explained by its 
different RNA class and potentially different efficiency properties. Low performance of miR-16 as normalizer was 
reported in prostate carcinomas24. In addition miR-16 appeared deregulated by different cancer types22,24,35 and 
in myelodysplastic syndrome36.
The marked differences in performance of the tested normalization strategies had a significant impact on miRNAs 
profiling in AF, hindering biological implications. In the representative example of miR-499a-5p, we showed 
that normalization by the best reference gene pointed out differences in the expression levels between AF and SR 
patients, which were lost by applying the wrong normalization strategy. The observed difference in expression 
is in agreement with previous results in human atrial tissues from cardiac surgery patients, where miR-499a-5p 
resulted significantly upregulated in AF37. In particular, the study showed that miR-499a-5p overexpression led 
to a downregulation of the protein expression of the small-conductance calcium-activated potassium channel 3, 
which may potentially contribute to AF electrical remodeling37. Interestingly, in ref. 37 miRNA expression was 
normalized to GAPDH messenger RNA from the same preparation. The observation of similar expression pro-
files in presence of different normalization strategies may add further consistency to our results.
Limitations. Cq values were estimated in each patient from a single tissue sample. Thus the observed 
variability may be related not only to the population, but also to the tissue sampling step (see Supplementary 
Analysis of Variability and Fig. 1S). When allowed by the clinical setting, evaluation of miRNA expression from 
human cardiac tissue should be performed from multiple samples in each individual to reduce overall varia-
bility38. As well, normalization performance may be improved by using SNORD48 in combination with other 
reference genes16, but optimal reference gene combination needs further investigation.
Conclusion
This study pointed out the unreliable performance of reference gene U6 in AF studies involving human atrial 
tissue samples from cardiac surgery settings, and suggests instead the use of SNORD48 as single normalizer of 
miRNA expression. Our results stress the importance of testing and validating reference genes in each specific 
experimental and disease condition. In order to avoid the continuous emergence of divergent and contradictory 
conclusions in the study of miRNAs and AF, a consensus on data normalization is urged before miRNAs are fur-
ther quantified using relative qPCR in human AF.
www.nature.com/scientificreports/
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Materials and Methods
Sample collection. Tissue samples from the right atrial appendage were excised during open cardiac sur-
gery in 18 patients, undergoing aortic or mitral valve replacement with extracorporeal circulation at the Santa 
Chiara Hospital of Trento. The patients were all males, with a mean age of 70.7 ± 10.6 years (range 44–85 years). 
The patients were divided into two groups: patients in normal SR (n = 11, without history of AF) and patients 
with AF (n = 7, documented arrhythmia >6 months before surgery). Demographic and clinical details about 
the population are reported in Table 4. The investigation was approved by the Ethical Committee for Clinical 
Experimentation of the Provincial Agency for Health Services of the Autonomous Province of Trento, and con-
ducted according to the tenets of the Declaration of Helsinki. All patients gave written informed consent.
Sample processing and RNA isolation. Small right atrial appendage biopsies (~30–50 mg) were flash 
frozen in pre-chilled liquid isopentane and stored at −80 °C until RNA isolation. Each frozen tissue sample was 
placed in a sterile 15 ml polypropylene tube containing 1,5 ml of pre-cooled Qiazol reagent (Qiagen, Milan, Italy) 
and subsequently homogenized in ice by a Polytron (Omni-TH International, Kennesaw, USA) at half speed. 
Total RNA was extracted using miRNeasy mini kit (Qiagen, Milan, Italy) according to the manufacturer’s pro-
tocol. RNA concentration and purity were assessed spectrophotometrically by Nanodrop ND-1000 (Thermo 
Scientific, Wilmington, DE, USA). RNA integrity was evaluated for each sample using Agilent 2100 Bioanalyzer 
(Agilent Technologies, Santa Clara, CA, USA) with RNA 6000 Nano Kit. We set the RNA Integtity Number (RIN) 
threshold for good RNA >5, considering the higher stability of miRNAs39,40. RNA aliquots were stored at −80 °C 
until use.
Selection of candidate reference genes. Candidate reference genes were selected based on a literature 
survey encompassing studies on miRNA normalization in the cardiac tissue and in the study of AF. Five reference 
genes of different RNA classes were identified: 5S rRNA, U6 snRNA, hsa-miR-16-5p, SNORD48 and SNORD44 
snoRNAs. Specifications on the five reference genes are reported in Table 1.
Reverse transcription. The total RNA isolated from each tissue sample was reverse-transcribed using miR-
CURY LNATM Universal cDNA Synthesis kit II (Exiqon, Vedbaek, Denmark), containing 2 μl of Reaction Buffer 
5X, 1 μl of Enzyme mix, 10 ng of RNA in a reaction volume of 10 μl, according to the manufacturer’s protocol 
(Exiqon: Cat. No. 203301, Version 6.1, 04/2015). The reaction conditions were: incubation at 42 °C for 60 minutes, 
heat-inactivation of the reverse transcriptase at 95 °C for 5 minutes, cooling and storage at 4 °C. The retrotran-
scription was realized by adding a poly-A tail to the mature miRNA template and synthesizing the cDNA by a 
poly-T primer with a 3′ degenerate anchor and a 5′ universal tag.
qPCR. qPCR assays based on SYBR Green I were performed on the five reference genes and on hsa-miR-499a-5p 
according to the manufacturer’s protocol (Exiqon: Cat. No. 203403, Version 6.1, 04/2015). miRCURY LNATM 
PCR primers set for 5S rRNA (Assay ID: 203906; batch number: 176192), U6 snRNA (Assay ID: 203907; batch 
number: 164846), hsa-miR-16-5p (Assay ID: 205702; batch number: 159156), SNORD48 snoRNA (Assay ID: 
203903; batch number: 171942), SNORD44 snoRNA (Assay ID: 203902; batch number: 171664), and 
SR group (n = 11) AF group (n = 7) p
Age (years) 67 ± 12 76 ± 4 ns
Men, n (%) 11 (100) 7 (100) ns
Aortic valve disease, n (%) 7 (64) 5 (71) ns
Mitral valve disease, n (%) 1 (9) 3 (43) ns
Coronary artery disease, n (%) 3 (27) 1 (14) ns
Angina pectoris, n (%) 6 (55) 2 (29) ns
Chronic obstructive pulmonary 
disease, n (%) 1 (9) 1 (14) ns
Diabetes Mellitus, n (%) 2 (18) 1 (14) ns
Hypertension, n (%) 7 (64) 7 (100) ns
Renal insufficiency, n (%) 1 (9) 1 (14) ns
Metabolic disease, n (%) 3 (27) 3 (43) ns
Dilated left atrium (diameter 
≥ 41 mm), n (%) 7 (64) 4 (57) ns
LV EF, % 64.5 [62–68] 60 [53.5–68.5] ns
Isolated AVR, n (%) 3 (27) 2 (29) ns
Isolated MVR, n (%) 0 (0) 2 (29) ns
Combined AVR and CABG, n (%) 6 (55) 3 (43) ns
Combined MVR and CABG, n (%) 2 (18) 0 (0) ns
Table 4.  Demographic and clinical description of the patient population. The two patient subgroups 
correspond to patients in sinus rhythm (SR) or atrial fibrillation (AF). Data are numbers (n) or percentages (%), 
and mean ± standard deviation or median [interquartile range], as pertinent. AVR, aortic valve replacement; 
CABG, coronary artery bypass grafting; LV EF, left ventricular ejection fraction; MVR, mitral valve 
replacement; ns, non-significant.
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hsa-miR-499a-5p (Assay ID: 205935; batch number: 190086) were purchased from Exiqon (Vedbaek, Denmark). 
hsa-miR-499a-5p was analyzed to evaluate the effects of different normalization strategies on miRNA profiling. 
Both forward and reverse primers were miRNA-specific and optimized with LNATM. qPCR reactions were per-
formed using ExiLENT SYBR® Green master mix (Exiqon, Vedbaek, Denmark) in a CFX384 Real-Time PCR 
Detection System (Bio-Rad Laboratories, Milan, Italy). The 10 μl PCR reaction contained 4 μl of the diluted cDNA 
template, 5 μl of SYBR® Green master mix and 1 μl of PCR primer mix. The reaction protocol was as follows: 95 °C 
for 10 minutes, followed by 40 amplification cycles at 95 °C for 10 seconds and 60 °C for 1 minute. Each sample was 
assessed in technical triplicates. Replicates at the qPCR step were used to ensure against a failed reaction so that 
the data point was not missed. qPCR no template controls (NTCs) were run to set the background level. No sign 
of contamination was observed. The Cq was determined using Bio-Rad CFX Manager (Bio-Rad Laboratories Inc., 
Hercules, California, US) and single threshold method. Cq values were estimated for each patient and gene as the 
average of the technical triplicates Cq, after removal of the outliers (Cq values that differed more than 1 from the 
triplicate median). Cq values or −E Cq expression values (where the amplification efficiency, E, was assumed equal 
to 2) were used as inputs for subsequent stability analysis. Normalized expression for the gene of interest (GOI, 
miR-499a-5p) with respect to a specific reference gene (RG) was given by E−dCq, where dCq = CqGOI − CqRG.
Assessment of reference gene stability. Gene expression stability was evaluated according to four 
gold-standard statistical approaches: BestKeeper15, GeNorm16, the comparative delta-Cq method18, and 
NormFinder17.
BestKeeper15 assumes that reliable reference genes should display low variability and similar expression pat-
terns. Variability is assessed by computing the SD of the reference gene Cq, and genes with SD >1 are considered 
inadequate. Pattern similarity is evaluated by calculating Pearson’s linear correlation coefficients (r) of all possible 
pairs of reference genes, and of the reference genes with the BestKeeper Index (BKI). This is obtained as the 
geometric mean of the Cq values of the reference genes in each sample. Genes with low SD and high correlation 
coefficients are the most stable.
GeNorm16 is based on the assumption that the expression ratio of two reference genes should be constant 
across samples. Gene stability is assessed computing the M-value, which is defined as the average pairwise var-
iation of a particular reference gene with all other reference genes. Genes with the lowest M-value are the most 
stable. A repeated process of stepwise exclusion of the worst scoring reference gene is performed till the best pair 
of reference genes is identified. In addition, GeNorm computes the pairwise variation coefficient (V-value) to 
determine the optimal number of reference genes for a more accurate normalization. If the V-value is less or equal 
to a 0.15 cut-off value, it is not necessary to add further genes for normalization.
The delta-Cq method18 is based on assumptions similar to GeNorm, but pairs of reference genes are quanti-
tatively compared in terms of the variability of their Cq differences (ΔCq) over the samples. The stability of each 
gene is quantified as the average SD over the pairwise comparisons with all other reference genes. Genes with the 
lowest average SD are the most stable.
NormFinder17 is based on a solid mathematical model of gene expression and statistical framework, which 
allows to estimate not only the overall expression variation of the candidate genes, but also the variations between 
sample subgroups of the same set (e.g., disease vs control subjects). For each reference gene a stability value ρ is 
computed, which takes into account both intra- and inter-group variations. Genes with the lowest ρ-value are the 
most stable. In addition, NormFinder can compute an average stability value (ρA) for combinations of reference 
genes to assess if the average of these reference genes can improve stability with respect to the use of a single refer-
ence gene. In this study, the ρA index was computed for each combination of two reference genes.
The overall performance of the reference genes was evaluated by combining the results of the four analyses31. 
Specifically, a global ranking of the genes was obtained as the geometric mean of the rankings given by each 
analysis.
Statistical analysis. Categorical variables were expressed as numbers or percentages. Statistical differ-
ences between categorical data were evaluated by Pearson’s Chi Square test. Continuous variables were given by 
mean ± SD or median (IQR), depending on data normality (assessed by Lilliefors test). Consistently, statistical 
differences between continuous variables were evaluated by unpaired Student t-test or Wilcoxon-Mann-Whitney 
test. A p < 0.05 was considered statistically-significant.
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